Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00889408
What this trial is testing

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT00475150
What this trial is testing

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more
National Cancer Institute (NCI) 39
Not applicableLooking for participantsNCT06956755
What this trial is testing

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
Groupe Francophone des Myelodysplasies 6,990
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07766850
What this trial is testing

Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
R/R AML
Christer C Nilsson 26
Large-scale testing (Phase 3)Looking for participantsNCT05586074
What this trial is testing

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Who this might be right for
Leukemia, Acute Myeloid (AML)
Sunshine Lake Pharma Co., Ltd. 324
Early research (Phase 1)Study completedNCT01397799
What this trial is testing

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
Kinex Pharmaceuticals Inc. 24
Very early researchEnded earlyNCT06110208
What this trial is testing

Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

Who this might be right for
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 3
Large-scale testing (Phase 3)UnknownNCT03665480
What this trial is testing

The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Who this might be right for
Granulocyte Colony-stimulating FactorMinimal Residual DiseaseAcute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 122
Testing effectiveness (Phase 2)Study completedNCT00559091
What this trial is testing

Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

Who this might be right for
Acute Myelocytic Leukemia
Jewish General Hospital 18
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Not applicableLooking for participantsNCT06764459
What this trial is testing

Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments

Who this might be right for
Myeloid Leukemia, Acute
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Testing effectiveness (Phase 2)Study completedNCT03839446
What this trial is testing

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Who this might be right for
Acute Myeloid Leukemia
Robert Redner, MD 16
Early research (Phase 1)Study completedNCT01613976
What this trial is testing

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Testing effectiveness (Phase 2)Study completedNCT02509546
What this trial is testing

8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00607997
What this trial is testing

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Who this might be right for
LeukemiaAcute DiseaseAcute Myeloid Leukemia+2 more
Sunesis Pharmaceuticals 113
Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Early research (Phase 1)Looking for participantsNCT07025564
What this trial is testing

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Next Page